Abstract:Ferroptosis, a distinct form of cell death, is characterized by the iron-mediated oxidation of lipids and is finely controlled by multiple cellular metabolic pathways. These pathways encompass redox balance, iron regulation, mitochondrial function, as well as amino acid, lipid, and sugar metabolism. Additionally, various disease-related signaling pathways also play a role in the regulation of ferroptosis. In recent years, with the introduction of the concept of ferroptosis and the deepening of research on its mechanism, ferroptosis is closely related to various biological conditions of eye diseases, including eye organ development, aging, immunity, and cancer. This article reviews the development of the concept of ferroptosis, the mechanism of ferroptosis, and its latest research progress in ophthalmic diseases and reviews the research on ferroptosis in ocular diseases within the framework of metabolism, active oxygen biology, and iron biology. Key regulators and mechanisms of ferroptosis in ocular diseases introduce important concepts and major open questions in the field of ferroptosis and related natural compounds. It is hoped that in future research, further breakthroughs will be made in the regulation mechanism of ferroptosis and the use of ferroptosis to promote the treatment of eye diseases. At the same time, natural compounds may be the direction of new drug development for the potential treatment of ferroptosis in the future. Open up a new way for clinical ophthalmologists to research and prevent diseases.

Discovery and optimization of olanzapine derivatives as new ferroptosis inhibitors

Discovery of 4-hydroxyl pyrazole derivatives as potent ferroptosis inhibitors

Design, synthesis, and biological evaluation of 2-amino-6-methyl-phenol derivatives targeting lipid peroxidation with potent anti-ferroptotic activities

Synthesis and biological evaluation of ferrostatin-based diamide derivatives as new ferroptosis inhibitors

Discovery of Novel Ortho -Aminophenol Derivatives Targeting Lipid Peroxidation with Potent Antiferroptotic Activities

Identification of Isoliensinine as a Ferroptosis Suppressor with Iron-Chelating Activity

Discovery of novel diphenylbutene derivative ferroptosis inhibitors as neuroprotective agents

Design, Synthesis, and Biological Evaluation of New Improved Ferrostatin‐1 Derived Ferroptosis Inhibitors

Design and synthesis of sulfonamide phenothiazine derivatives as novel ferroptosis inhibitors and their therapeutic effects in spinal cord injury

Discovery of a NCOA4 Degrader for Labile Iron-Dependent Ferroptosis Inhibition

Design, synthesis, and evaluation of formylpiperazine analogs of Ferrostatin-1 as novel improved ferroptosis inhibitors

Identification of Marine-Derived SLC7A11 Inhibitors: Molecular Docking, Structure-Based Virtual Screening, Cytotoxicity Prediction, and Molecular Dynamics Simulation

Radical Scavenging and Anti-Ferroptotic Molecular Mechanism of Olanzapine: Insight from a Computational Analysis

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors

Ferroptosis inhibitors: past, present and future

Targeting ferroptosis opens new avenues for the development of novel therapeutics

Ferroptosis: A new strategy for targeting Alzheimer's disease

Inhibiting Ferroptosis through Disrupting the NCOA4–FTH1 Interaction: A New Mechanism of Action

Natural compounds efficacy in Ophthalmic Diseases: A new twist impacting ferroptosis

Natural product-derived ferroptosis mediators

Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases